Copyright: ©Author(s) 2026.
World J Transl Med. Nov 28, 2026; 12(4): 124606
Published online Nov 28, 2026. doi: 10.5528/wjtm.124606
Published online Nov 28, 2026. doi: 10.5528/wjtm.124606
Table 1 Lipoprotein(a) concentration and cardiovascular risk categories
| Cardiovascular risk category | Lp(a) concentration (mg/dL) | Lp(a) concentration (nmol/L) | Ref. |
| Low risk | < 30 mg/dL | < 75 nmol/L | Grundy et al[21] |
| Intermediate risk | 30-50 mg/dL | 75-125 nmol/L | |
| High risk | ≥ 50 mg/dL | ≥ 125 nmol/L |
- Citation: Feliciano LD, Freire JPC, Lopes CF, Lima PHM, Costa JMC, de Melo FF. Lipoprotein(a) in clinical practice: From genetic risk assessment to therapeutic silencing. World J Transl Med 2026; 12(4): 124606
- URL: https://www.wjgnet.com/2220-6132/full/v12/i4/124606.htm
- DOI: https://dx.doi.org/10.5528/wjtm.124606